FLT3 and acute myeloid leukemia: FLT3-ITD defines an activating mutation of the Fms-like tyrosine kinase 3 (FLT3) known as internal tandem duplication (ITD), which is known to arbitrate resistance of AML, enhance survival [163], as well as promote proliferation in hematopoietic cells [164].